Innate Pharma SA Increase Decrease In Cash And Cash Equivalents Discontinued Operations
Innate Pharma SA (IPHA) reported Increase Decrease In Cash And Cash Equivalents Discontinued Operations of EUR 0 for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations · last filed 2025-04-30
| Period end | Increase Decrease In Cash And Cash Equivalents Discontinued Operations 6 month | Increase Decrease In Cash And Cash Equivalents Discontinued Operations 12 month |
|---|---|---|
| 2024-12-31 | 0.00 EUR 20-F · filed 2025-04-30 | |
| 2023-12-31 | 0.00 EUR 20-F · filed 2025-04-30 | |
| 2023-06-30 | 0.00 EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | -5.10M EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | -5.54M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | -3.55M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | -4.40M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | -29.01M EUR 20-F · filed 2023-04-06 | |
| 2019-12-31 | -65.23M EUR 20-F · filed 2022-04-04 |